Poland's Bioton signs Russian insulin deal with GSK
This article was originally published in Scrip
Executive Summary
The Polish contract manufacturer/biotech firm Bioton has signed a 15-year supply agreement with GlaxoSmithKline where the multinational will distribute its insulin products (Gensulin/GensuPen) in Russia.